Tejnaksh Healthcare Ltd

Fri 4/09/2026,15:17:0 | BSE : TEJNAKSH

₹13.940.20 (1.46%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 13.74

Previous Close

₹ 13.74

Volume

2178

Mkt Cap ( ₹ Cr)

₹ 28.32

High

₹ 13.94

Low

₹ 13.37

52 Week High

₹ 19.85

52 Week Low

₹ 10.65

Book Value Per Share

₹ 13.49

Dividend Yield

₹ 0.00

Face Value

₹₹5.00

What's Your Call?

Collective community sentiment on Tejnaksh Healthcare Ltd

Your Vote -

Buy

66.67%

Hold

0.00%

Sell

33.33%

66.67%

3 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Tejnaksh Healthcare Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Tejnaksh Healthcare - Reg. 34 (1) Annual Report.

    4 Sep 2026, 1:14PM Dear Sir / Madam\r\nWith reference to captioned subject find enclosed herewith Annual Report of the Company for the F.Y.\r\n2025-26\r\nKindly take the
  • Tejnaksh Healthcare - Notice Of 19Th Annual General Meeting Of The Company To Be Held On 29Th September, 2026

    4 Sep 2026, 12:58PM This to inform that the 19th Annual General meeting to be held on 29th September 2026. Notice is attached for your reference
  • Tejnaksh Healthcare - Submission Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended On 30 June

    13 Aug 2026, 6:52PM Please find attached unaudited FS as of June 26
  • Tejnaksh Healthcare - Board Meeting Outcome for Outcome Of- Board Meeting In Accordance 'With SEBI (Listing Obligations And\r

    13 Aug 2026, 6:39PM In continuation of our Letter dated 08th August, 2026 we wish to inform you that a meeting oft he\r\nBoard of Directors of the Company was held on Thu
  • Tejnaksh Healthcare - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations

    8 Aug 2026, 7:00PM Tejnaksh Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider
  • Tejnaksh Healthcare has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026

    20 Jul 2026, 7:00AM As of June 2026, 73.83% is owned by Indian Promoters and 26.17% by Public. <p align=justify> Top three Promoters holding highest number of shares of T
  • Tejnaksh Healthcare - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    19 Jul 2026, 11:25PM Respected Sir/Madam,\r\n\r\nPlease compliance certificate under Reg. 74(5) of SEBI(DP) Reg 2018.

Key fundamentals

Evaluate the intrinsic value of Tejnaksh Healthcare Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 26.7955 26.0404 26.886 26.8776 25.8822
Liabilities 26.7955 26.0404 26.886 26.8776 25.8822
Equity 10.1568 10.1568 10.1568 10.1568 10.1568
Gross Profit 2.8563 4.4757 3.6393 3.1304 4.3031
Net Profit 1.3798 2.6215 1.8125 1.3799 2.5188
Cash From Operating Activities 1.7922 0.4807 4.1461 1.9032 9.1263
NPM(%) 19.22 29.79 22.04 18.81 31.02
Revenue 7.1772 8.7978 8.2215 7.3351 8.1178
Expenses 4.3209 4.3221 4.5822 4.2047 3.8147
ROE(%) 5.03 9.56 6.61 5.03 9.18

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Tejnaksh Healthcare Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 863.00 -0.52 21.76 7.96 -26.19 0.58
Lotus Eye Hospital and Institute Ltd 109.90 -0.68 1563.29 28.99 0.39 0.00
Bharat Immunological and Biologicals Corporation Ltd 15.42 0.72 0.00 60.19 -39.50 0.00
Astec Lifesciences Ltd 552.30 -3.93 0.00 31.06 -363.14 0.00

Company Info

The Company incorporated in Mumbai as "Tejnaksh Healthcare Private Limited" as on 18th February, 2008 as a private limited company under provision of companies Act 1956. Company was converted in to a Public Limited Company and consequently the name was changed to "Tejnaksh Healthcare Limited" vide fresh certificate of incorporation dated 10th March, 2015 issued by the Registrar of Companies, Mumbai, Maharashtra.We run an Institute of Urology, an ISO certified the international level Urology hospital, located in the heart of Dhule city, Maharashtra, India. The 24000 Sq. Ft. campus has a four storey building which houses the complete Urology setup. It provides a comprehensive range of services from consultations and investigations to treatment for Urology.We are equipped with all latest equipment and provide the whole range of services, the patients from local area do not feel the need to go to metropolitan areas for urological problems. The Institute is recognized by National board of examinations for DNB (Urology). The Institute boasts of 150 research publications and 23 innovations.We are a professionally managed and growing organization which aims at strengthening and establishing itself as the foremost provider of healthcare services. We also aim at achieving greater and long-term growth. the Managing Director and Promoter Dr. Ashish Vishwas Rawandale is listed in Guinness World Records (twice), Ripley's believe it or not, Limca book of records, India book of records (multiple records), Asia book of records, World amazing records and World record academy for various achievements and innovations in urology. The objective of the Hospital namely Institute of Urology is to provide the people of Khandesh region of Maharashtra, the services of a super specialty hospital at an affordable rate. We are an integrated healthcare delivery service provider, committed to delivering quality healthcare services to the patients in modern facilities. the operations are divided across four key vertical streams in healthcare delivery, namely - "Pediatric Urology", "Adult Urology (Male, Female)", "Andrology and Sexual Dysfunction" and "Nephrology, Dialysis and Renal Transplant". The registered office of the Company was initially situated at 6th Floor, A Block, Shivsagar Estate, Dr. Annie Besant Road, Worli, Mumbai - 400 025. Pursuant to a Board resolution dated 13th March, 2015 the registered office was shifted to Unit No.11, Ground Floor, Town Centre, Andheri Kurla Road, Marol, Andheri (East), Mumbai-400 059, which is the current Registered Office.  MAJOR EVENTS AND MILESTONES: 2008 -Incorporation of the Company in the name and style of "Tejnaksh Healthcare Private Limited" -Set up Hospital in Dhule, Maharashtra 2014 -ISO Certification 2015 -Conversion in to a Public Limited Company 2016 -Tejnaksh Healthcare Ltd. has acquired Vedaant Multispecialty Hospital situated at Office No. 1 to 14, Natasha Tower CHS Ltd., Plot No. 84, Sector 17, Village Koparkhairane, Taluka and District Thane. 2017 -The Company has issued Bonus Shares in the Ratio of 1:1. 2018 -The Company has issued Bonus Shares in the Ratio of 36:10. 2023 -The Company has splits its face value from Rs. 10/- to Rs. 5/-. 2023-The Company has splits its face value from Rs. 10/- to Rs. 5/--The company has successfully demonstrated PFLOW product of our company

The Company incorporated in Mumbai as "Tejnaksh Healthcare Private Limited" as on 18th February, 2008 as a private limited company under provision of companies Act 1956. Company was converted in to a Public Limited Company and consequently the name was changed to "Tejnaksh Healthcare Limited" vide fresh certificate of incorporation dated 10th March, 2015 issued by the Registrar of Companies, Mumbai, Maharashtra.We run an Institute of Urology, an ISO certified the international level Urology hospital, located in the heart of Dhule city, Maharashtra, India. The 24000 Sq. Ft. campus has a four storey building which houses the complete Urology setup. It provides a comprehensive range of services from consultations and investigations to treatment for Urology.We are equipped with all latest equipment and provide the whole range of services, the patients from local area do not feel the need to go to metropolitan areas for urological problems. The Institute is recognized by National board of examinations for DNB (Urology). The Institute boasts of 150 research publications and 23 innovations.We are a professionally managed and growing organization which aims at strengthening and establishing itself as the foremost provider of healthcare services. We also aim at achieving greater and long-term growth. the Managing Director and Promoter Dr. Ashish Vishwas Rawandale is listed in Guinness World Records (twice), Ripley's believe it or not, Limca book of records, India book of records (multiple records), Asia book of records, World amazing records and World record academy for various achievements and innovations in urology. The objective of the Hospital namely Institute of Urology is to provide the people of Khandesh region of Maharashtra, the services of a super specialty hospital at an affordable rate. We are an integrated healthcare delivery service provider, committed to delivering quality healthcare services to the patients in modern facilities. the operations are divided across four key vertical streams in healthcare delivery, namely - "Pediatric Urology", "Adult Urology (Male, Female)", "Andrology and Sexual Dysfunction" and "Nephrology, Dialysis and Renal Transplant". The registered office of the Company was initially situated at 6th Floor, A Block, Shivsagar Estate, Dr. Annie Besant Road, Worli, Mumbai - 400 025. Pursuant to a Board resolution dated 13th March, 2015 the registered office was shifted to Unit No.11, Ground Floor, Town Centre, Andheri Kurla Road, Marol, Andheri (East), Mumbai-400 059, which is the current Registered Office.  MAJOR EVENTS AND MILESTONES: 2008 -Incorporation of the Company in the name and style of "Tejnaksh Healthcare Private Limited" -Set up Hospital in Dhule, Maharashtra 2014 -ISO Certification 2015 -Conversion in to a Public Limited Company 2016 -Tejnaksh Healthcare Ltd. has acquired Vedaant Multispecialty Hospital situated at Office No. 1 to 14, Natasha Tower CHS Ltd., Plot No. 84, Sector 17, Village Koparkhairane, Taluka and District Thane. 2017 -The Company has issued Bonus Shares in the Ratio of 1:1. 2018 -The Company has issued Bonus Shares in the Ratio of 36:10. 2023 -The Company has splits its face value from Rs. 10/- to Rs. 5/-. 2023-The Company has splits its face value from Rs. 10/- to Rs. 5/--The company has successfully demonstrated PFLOW product of our company

Parent Organisation

Tejnaksh Healthcare Ltd.

Founded

18/02/2008

Managing Director

Dr.Ashish Vishwas Rawandale

NSE Symbol

FAQ